Mesenchymal stem cells in tissue engineering

Journal of Chemical Technology and Biotechnology

Volumn 83, Issue 4, 2008, Pages 397-407

  Godara, Pankaj ^a   Nordon, Robert E ^a   McFarland, Clive D ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Differentiation; Mesenchymal stem cell; MSC; TE; Tissue engineering

Indexed keywords

CELLS; DIFFERENTIATION (CALCULUS); DRUG THERAPY;

MESENCHYMAL LINEAGES; MESENCHYMAL STEM CELL;

TISSUE ENGINEERING;

MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

CELLS; DIFFERENTIATION (CALCULUS); DRUG THERAPY; TISSUE ENGINEERING;

ADULT STEM CELL; ANTIGEN EXPRESSION; BONE DEFECT; BONE GRAFT; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL LABELING; CELL LINEAGE; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CHONDROPATHY; EMBRYONIC STEM CELL; HEART INFARCTION; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOARTHRITIS; PLASTICITY; SHORT SURVEY; SKIN INJURY; SKIN TRANSPLANTATION; SOFT TISSUE DEFECT; STROMA CELL; TISSUE DISTRIBUTION; TISSUE ENGINEERING;

EID: 41549098692     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.1901     Document Type: Short Survey

References (132)

1. McDiarmid SV, Current status of liver transplantation in children. Pediatr Clin North Am 50:1335-1374 (2003).
2. Langer R and Vacanti JP, Tissue engineering. Science 260:920-9266 (1993).
3. Berthiaume F and Yarmush ML, Tissue engineering, in The Biomedical Engineering Handbook, ed. by Bronzino JD. CRC Press. pp. 109-1-109-12 (2000).
4. Griffith LG and Naughton G, Tissue engineering- current challenges and expanding opportunities. Science 295:1009-1014 (2002).
5. Ingber DE, et al, Tissue engineering and developmental biology: going biomimetic. Tissue Eng 12:3265-3283 (2006).
6. Bianco P and Robey PG, Stem cells in tissue engineering. Nature 414:118-121 (2001).
7. Barry FP, Biology and clinical applications of mesenchymal stem cells. Birth Defects Res Part C Embryo Today 69:250-256 (2003).
8. Donovan PJ and Gearhart J, The end of the beginning for pluripotent stem cells. Nature 414:92-97 (2001).
9. Vaananen HK, Mesenchymal stem cells. Ann Med 37:469-479 (2005).
10. da Silva Meirelles L, Chagastelles PC and Nardi NB, Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204-2213 (2006).
11. Le Blanc K, et al, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441 (2004).
12. Smith A, A glossary for stem-cell biology. Nature 441:1060 (2006).
13. Clarke D and Frisen J, Differentiation potential of adult stem cells. Curr Opin Genet Dev 11:575-580 (2001).
14. Kopen GC, Prockop DJ and Phinney DG, Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96:10711-10716 (1999).
15. Sato Y, et al, Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 106:756-763 (2005).
16. O'Donoghue K and Fisk NM, Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 18:853-875 (2004).
17. Campagnoli C, et al, Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402 (2001).
18. Rogers I and Casper RF, Umbilical cord blood stem cells. Best Pract Res Clin Obstet Gynaecol 18:893-908 (2004).
19. Bieback K, et al, Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634 (2004).
20. Wang HS, et al, Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337 (2004).
21. Bongso A and Lee EH, Stem cells: their definition classification and sources in Stem Cells From Bench to Bedside, ed. by Bongso A and Lee EH. World Scientific, Singapore (2005).
22. Baksh D, Song L and Tuan RS, Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8:301-316 (2004).
23. Bianco P and Gehron Robey P, Marrow stromal stem cells. J Clin Invest 105: 1663-1668 (2000).
24. Javazon EH, Beggs KJ and Flake AW, Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32:414-425 (2004).
25. Caplan AI and Bruder SP, Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7:259-264 (2001).
26. Kassem M, Kristiansen M and Abdallah BM, Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol 95:209-214 (2004).
27. Roufosse CA, et al, Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36:585-597 (2004).
28. Koc ON and Lazarus HM, Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant 27:235-239 (2001).
29. Minguell JJ, Conget P and Erices A, Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res 33:881-887 (2000).
30. Vacanti CA and Vacanti JP, The science of tissue engineering. Orthop Clin North Am 31:351-356 (2000).
31. Caplan AI, Mesenchymal stem cells. J Orthop Res 9:641-650 (1991).
32. Friedenstein AJ, Chailakhjan RK and Lalykina KS, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403 (1970).
33. Castro-Malaspina H, et al, Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289-301 (1980).
34. Owen M and Friedenstein AJ, Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136:42-60 (1988).
35. Morrison SJ and Kimble J, Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441:1068-1074 (2006).
36. Bianchi G, et al, Microenvironment and stem properties of bone marrow-derived mesenchymal cells. Wound Repair Rege, 9:460-406 (2001).
37. Fehrer C and Lepperdinger G, Mesenchymal stem cell aging. Exp Gerontol 40:926-930 (2005).
38. Parsch D, et al, Telomere length and telomerase activity during expansion and differentiation of human mesenchymal stem cells and chondrocytes. J Mol Med 82:49-55 (2004).
39. Zimmermann S, et al, Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17:1146-1149 (2003).
40. Baxter MA, et al, Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675-682 (2004).
41. Barry FP and Murphy JM, Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568-584 (2004).
42. Young HE, et al, Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264:51-62 (2001).
43. Zvaifler NJ, et al, Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2:477-488 (2002).
44. He Q, Wan C and Li G, Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25:69-77 (2007).
45. Dazzi F, et al, The role of mesenchymal stem cells in haemopoiesis. Blood Rev 20:161-71 (2006).
46. Schofield R, The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4:7-25 (1978).
47. Scadden DT, The stem-cell niche as an entity of action. Nature 441:1075-1079 (2006).
48. Kolf CM, Cho E and Tuan RS, Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9:204 (2007).
49. Owen M, Marrow stromal stem cells. J Cell Sci 10:suppl: 63-76 (1988).
50. Deans RJ and Moseley AB, Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28:875-884 (2000).
51. Mauney JR, Volloch V and Kaplan DL, Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11:787-802 (2005).
52. Bianco P, et al, Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192 (2001).
53. Short B, et al, Mesenchymal stem cells. Arch Med Res 34:565-571 (2003).
54. Gronthos S, et al, Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 28:174-181 (2001).
55. Jaiswal N, et al, Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312 (1997).
56. Johnstone B, et al, In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272 (1998).
57. Yoo JU, et al, The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-1757 (1998).
58. Bennett JH, et al, Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 99:131-139 (1991).
59. Justesen J, et al, Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 71:36-44 (2002).
60. Park SR, Oreffo RO and Triffitt JT, Interconversion potential of cloned human marrow adipocytes in vitro. Bone 24:549-554 (1999).
61. Pittenger MF, et al, Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147 (1999).
62. Minguell JJ, Erices A and Conget P, Mesenchymal stem cells. Exp Biol Med (Maywood) 226:507-520 (2001).
63. Satija NK, et al, Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 16:7-23 (2007).
64. Jiang Y, et al, Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49 (2002).
65. Odelberg SJ, Inducing cellular dedifferentiation: a potential method for enhancing endogenous regeneration in mammals. Semin Cell Dev Biol 13:335-343 (2002).
66. Zhao W, et al, Neonatal pancreatic cells redifferentiate into both neural and pancreatic lineages. Biochem Biophys Res Commun 352:84-90 (2007).
67. Jackson L, et al, Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 53:121-127 (2007).
68. Diaz-Romero J, et al, Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Physiol 202:731-742 (2005).
69. Li Y, et al, Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105:635 -637 (2005).
70. Takahashi K and Yamanaka S, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676 (2006).
71. Okita K, Ichisaka T and Yamanaka S, Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317 (2007).
72. Takahashi K, et al, Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872 (2007).
73. Yu J, et al, Induced pluripotent stem cell lines derived from human somatic cells. Science (2007). Latest info. required.
74. Nakagawa M, et al, Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol (2007). Latest info required.
75. Prockop DJ, Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 276:71-74 (1997).
76. Gronthos S, et al, Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835 (2003).
77. Cai J, Weiss ML and Rao MS, In search of "stemness". Exp Hematol 32:585-598 (2004).
78. Simmons PJ and Torok-Storb B, Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55-62 (1991).
79. Sethe S, Scutt A and Stolzing A, Aging of mesenchymal stem cells. Ageing Res Rev 5:91-116 (2006).
80. Cai J, et al, Membrane properties of rat embryonic multipotent neural stem cells. J Neurochem 88:212-226 (2004).
81. Gimble JM, Katz AJ and Bunnell BA, Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249-1260 (2007).
82. Majumdar MK, et al, Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10:228-241 (2003).
83. Zangi L, et al, High-yield isolation, expansion, and differentiation of rat bone marrow-derived mesenchymal stem cells with fibrin microbeads. Tissue Eng 12:2343-2354 (2006).
84. Alhadlaq A and Mao JJ, Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13:436-448 (2004).
85. Hung SC, et al, Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 20:249-258 (2002).
86. Jones EA, et al, Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum 46:3349-3360 (2002).
87. Battula VL, et al, Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291 (2007).
88. Fukuchi Y, et al, Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22:649-658 (2004).
89. Miao Z, et al, Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30:681-687 (2006).
90. Grove JE, Bruscia E and Krause DS, Plasticity of bone marrow-derived stem cells. Stem Cells 22:487-500 (2004).
91. Bruder SP, et al, The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80:985-996 (1998).
92. Kadiyala S, et al, Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6:125-134 (1997).
93. Derubeis AR and Cancedda R, Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng 32:160-165 (2004).
94. Bruder SP and Fox BS, Tissue engineering of bone. Cell based strategies. Clin Orthop 367:(Suppl): S68-S83 (1999).
95. Salgado AJ, Coutinho OP and Reis RL, Bone tissue engineering: state of the art and future trends. Macromol Biosci 4:743-765 (2004).
96. Meyer U, Joos U and Wiesmann HP, Biological and biophysical principles in extracorporal bone tissue engineering. Part II. Int J Oral Maxillofac Surg 33:325-332 (2004).
97. Meyer U, Joos U and Wiesmann HP, Biological and biophysical principles in extracorporal bone tissue engineering. Part II. Intl Oral Maxillofac Surg 33:523-530 (2004).
98. Meyer U, Joos U and Wiesmann HP, Biological and biophysical principles in extracorporal bone tissue engineering. Part III. Int J Oral Maxillofac Surg 33:635-641 (2004).
99. Wiesmann HP, Joos U and Meyer U, Biological and biophysical principles in extracorporal bone tissue engineering. Part II. Int J Oral Maxillofac Surg 33:523-530 (2004).
100. Glowacki J, In vitro engineering of cartilage. J Rehabil Res Dev 37:171-177 (2000).
101. Jackson DW, Simon TM and Aberman HM, Symptomatic articular cartilage degeneration: the impact in the new millennium. Clin Orthop 391:(Suppl): S14-S25 (2001).
102. Kuo CK, et al, Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol 18:64-73 (2006).
103. Waldman SD, et al, The use of specific chondrocyte populations to modulate the properties of tissue-engineered cartilage. J Orthop Res 21:132-138 (2003).
104. Risbud MV and Sittinger M, Tissue engineering: advances in in vitro cartilage generation. Trends Biotechnol 20:351-356 (2002).
105. Coutts RD, et al, Matrices for cartilage repair. Clin Orthop 391:(Suppl): S271-S279 (2001).
106. Wakitani S, et al, Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10:199-206 (2002).
107. Martin I, et al, Osteochondral tissue engineering. J. Biomech (2006). Latest info. required.
108. Patrick CW, Breast tissue engineering. Annu Rev Biomed Eng 6:109-130 (2004).
109. Patrick CW Jr, Adipose tissue engineering: the future of breast and soft tissue reconstruction following tumor resection. Semin Surg Oncol 19:302-311 (2000).
110. Hemmrich K and von Heimburg D, Biomaterials for adipose tissue engineering. Expert Rev Med Devices 3:635-645 (2006).
111. Gomillion CT and Burg KJ, Stem cells and adipose tissue engineering. Biomaterials 27:6052-6063 (2006).
112. Patrick CW Jr, Tissue engineering strategies for adipose tissue repair. Anat Rec 263:361-366 (2001).
113. Miura M, et al, Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region. Oral Dis 12:514-522 (2006).
114. Hong L, et al, Ex vivo adipose tissue engineering by human marrow stromal cell seeded gelatin sponge. Ann Biomed Eng 33:511-517 (2005).
115. Alhadlaq A, Tang M and Mao JJ, Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: implications in soft tissue augmentation and reconstruction. Tissue Eng 11:556-566 (2005).
116. Choi YS, Park SN and Suh H, Adipose tissue engineering using mesenchymal stem cells attached to injectable PLGA spheres. Biomaterials 26:5855-5863 (2005).
117. Zuk PA, et al, Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295 (2002).
118. Kern S, et al, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294-1301 (2006).
119. Ohnishi S and Nagaya N, Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure. Am J Nephrol 27:301-307 (2007).
120. Tomita S, et al, Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:11247-11256 (1999).
121. Orlic D, et al, Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705 (2001).
122. Minguell JJ and Erices A, Mesenchymal stem cells and the treatment of cardiac disease. Exp Biol Med (Maywood) 231:39-49 (2006).
123. Dengler TJ and Katus HA, Stem cell therapy for the infarcted heart ("cellular cardiomyoplasty"). Herz 27:598-610 (2002).
124. Pittenger MF and Martin BJ, Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95:9-20 (2004).
125. Zimmet JM and Hare JM, Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol 100:471-481 (2005).
126. Haider H and Ashraf M, Bone marrow stem cell transplantation for cardiac repair. Am J. Physiol Heart Circ Physiol 288:H2557-H2567 (2005).
127. Clark RA Ghosh K and Tonnesen MG, Tissue engineering for cutaneous wounds. JInvest Dermatol 127:1018-1029 (2007).
128. MacNeil S ' Progress and opportunities for tissue-engineered skin. Nature 445:874-880 (2007).
129. Horch RE, et al, Tissue engineering of cultured sldn substitutes. J Cell Mol Med 9:592-608 (2005).
130. Metcalfe AD and Ferguson MW, Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 4:413-437 (2007).
131. Falanga V, et al, Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 13:1299-1312 (2007).
132. Wu Y, et al, Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells (2007). Latest info required).